News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Nepal glacier collapse has killed at least 1,204 people and left more than 4,200 missing.
  • Officials say about 7,500 homes were destroyed and roughly 20,000 dwellings will need rebuilding.
  • Rescue teams and international experts continue searching hydropower tunnels for survivors.
  • Gaza farmers rebuilt a local seed bank to preserve heirloom crops on the territory's remaining cultivable land.
  • Aid workers warn the rebuilt seed stock covers only a fraction of Gaza's agricultural needs.
  • Bitcoin paused below $78,000 as traders awaited U.S. regulatory decisions.
  • Renewed U.S.-Iran tensions are increasing geopolitical risk and weighing on market sentiment.

Latest Articles

Founder Group Limited Announces 100 for 1 Share Combination

Founder Group Limited Announces 100 for 1 Share Combination

Founder Group Limited is implementing a 100-for-1 share consolidation effective September 1, 2026, aiming to regain compliance with Nasdaq marketplace listing rules and maintain its Nasdaq Capital Market listing. The share price adjustment will not affect shareholder ownership percentages, and fractional shares will be rounded up to whole shares. T…

IBEX Limited to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 10, 2026

IBEX Limited to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on September 10, 2026

IBEX Limited, a Nasdaq-listed global leader in outsourced business services and AI-powered customer experience solutions, announced it will release its fourth quarter and fiscal year 2026 financial results after market close on September 10, 2026. The company will hold a conference call and webcast to discuss results, recent developments, and busin…

Stifel Reports July 2026 Operating Data

Stifel Reports July 2026 Operating Data

Stifel Financial Corp. announced robust operating data for July 2026, showing record fee-based client assets of $240 billion, a 15% year-over-year increase, and total client assets rising 11%. The firm experienced solid growth in bank loans by 19% year-over-year and increased treasury deposits by 59% compared to the previous year. These results ref…

Alerus Financial Corporation Declares Cash Dividend on Common Shares and Announces New Stock Repurchase Program

Alerus Financial Corporation Declares Cash Dividend on Common Shares and Announces New Stock Repurchase Program

Alerus Financial Corporation announced a quarterly cash dividend increase of 4.76% to $0.22 per common share, payable October 9, 2026. Additionally, the company approved a new stock repurchase program authorizing up to 1.25 million shares, effective after completion or expiration of the prior program, expiring in August 2029. These actions reflect …

Capital City Bank Group, Inc. Announces Cash Dividend

Capital City Bank Group, Inc. Announces Cash Dividend

Capital City Bank Group, Inc., a financial holding company headquartered in Florida, announced a quarterly cash dividend of $0.27 per share, with an annualized dividend yield of 2.11%. The dividend is payable on September 22, 2026, to shareholders of record as of September 8, 2026. The company provides various banking and financial services primari…

IREN Reports FY26 Results

IREN Reports FY26 Results

IREN Limited announced its FY26 financial results, highlighting significant growth in AI Cloud Services revenue (8x increase), a new multi-year contract with a leading frontier AI lab, a largely sold-out 2026 capacity with $4bn contracted ARR, and expanded data center pipeline globally. The company executed capital-efficient GPU financings to suppo…

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

Outlook Therapeutics, a biopharmaceutical company, appointed Kevin Lundquist as CFO to lead the financial and operational infrastructure as it prepares for the U.S. commercial launch of its FDA-approved drug LYTENAVA™ for wet age-related macular degeneration. Lundquist brings over 20 years of experience in pharmaceutical finance and commercial oper…

Parsons Strengthens Leadership in Global Counter-Nuclear Smuggling Mission with Two New NNSA Task Orders

Parsons Strengthens Leadership in Global Counter-Nuclear Smuggling Mission with Two New NNSA Task Orders

Parsons Corporation has been awarded two new task orders under the National Nuclear Security Administration's Counter Nuclear Smuggling Systems Deployment contract. These awards cover design and deployment of counter-nuclear smuggling systems in 25 countries across the Middle East and Africa, enhancing Parsons' portfolio to seven task orders valued…

Zumiez Inc. to Report Fiscal 2026 Second Quarter Results

Zumiez Inc. to Report Fiscal 2026 Second Quarter Results

Zumiez Inc., a specialty retailer of apparel and accessories for young adults, will report its fiscal 2026 second quarter results on September 10, 2026. Following the release, the company will hold a conference call and webcast for investors and interested parties to discuss the financial performance and outlook. Zumiez operates 714 stores worldwid…

Pulmonx to Participate in Upcoming Investor Conferences

Pulmonx to Participate in Upcoming Investor Conferences

Pulmonx Corporation, a Nasdaq-listed company specializing in minimally invasive treatments for severe lung disease, will have its management team participate in two major investor conferences in September 2026. The company's products, including the FDA-approved Zephyr® Endobronchial Valve, are recognized in global treatment guidelines for severe em…

Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising

Scripps taps NBCU sales veteran to lead small and medium business growth and direct response advertising

The E.W. Scripps Company has hired Jen Carfley, formerly of NBCUniversal, as head of small and medium business growth and direct response advertising. Carfley will develop enterprise-wide strategies to connect SMB advertisers with Scripps' premium video inventory across multiple platforms, including local, national, linear, and connected TV. She wi…

Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Roivant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Roivant announced FDA approval of LISRAYA™ (brepocitinib), the first targeted oral therapy for adults with dermatomyositis (DM), a rare autoimmune disease. LISRAYA demonstrated robust efficacy in the largest DM clinical trial to date, improving muscle strength, skin symptoms, physical function, and reducing steroid dependence. The drug is now avail…

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Priovant Therapeutics announced FDA approval of LISRAYA™ (brepocitinib), a first-in-class TYK2/JAK1 inhibitor, for the treatment of adults with dermatomyositis, a rare systemic autoimmune disease. The approval follows positive Phase 3 VALOR trial results demonstrating significant improvements in disease activity and steroid-sparing benefits. LISRAY…

Anthropic Readies IPO Prospectus for Release After Labor Day, Eyes Late September or Early October Listing

Anthropic Readies IPO Prospectus for Release After Labor Day, Eyes Late September or Early October Listing

Anthropic plans to make its IPO prospectus public after Labor Day, with a potential market debut targeted for late September or early October. The firm, which confidentially filed earlier this year, is weighing whether to permit existing shareholders to sell in the offering and is considering lockup periods longer than the typical 180 days. The com…